Genome sequencing of Pasteurella multocida phage PMP1 elucidates a possible host resistance mechanism and suggests that it belongs to a new species
- PMID: 40637897
- DOI: 10.1007/s00705-025-06357-8
Genome sequencing of Pasteurella multocida phage PMP1 elucidates a possible host resistance mechanism and suggests that it belongs to a new species
Abstract
Pasteurella multocida, especially capsular serotype A, is a zoonotic pathogen that is found mainly in livestock. While antibiotics are commonly used to treat bacterial infections, bacteriophage therapy has become an important alternative due to the issue of antibiotic resistance. Although four virulent P. multocida-infecting phages have been described, their interactions with their hosts have not been extensively studied. In this study, a novel virulent phage, PMP1, was isolated from a livestock waste treatment facility in Korea. This phage has a short, non-contractile tail with an isometric head and specifically lyses toxA-negative serotype A strains but can adsorb to toxA-positive strains. PMP1 has a genome of 38,049 bp in length with no genes related to lysogeny. Bioinformatic analysis and transmission electron microscopy suggest that a toxA-containing prophage could be involved in the restriction-modification system; however, the correlationof the presence of toxA with phage resistance was not clearly established. The structural proteins were identified for the first time in a P. multocida-infecting phage by LC-MS/MS analysis, and phylogenetic analysis revealed that PMP1 could be a member of new species in the genus Wuhanvirus. These findings suggest that this phage should be investigated further as a potential anti-P. multocida agent.
Keywords: P. multocida; toxA; PMP1; antibiotics; phage; restriction-modification system.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: This article does not contain any experiment with humans or animals. Conflict of interest: The authors have no relevant financial or non-financial interests to disclose.
References
-
- Register KB, Brockmeier SL (2019) Pasteurellosis. In: Diseases of Swine. Wiley, pp 884–897
-
- Su A, Tong J, Fu Y, Müller S, Weldearegay YB, Becher P, Valentin-Weigand P, Meens J, Herrler G (2020) Infection of bovine well-differentiated airway epithelial cells by Pasteurella multocida: actions and counteractions in the bacteria–host interactions. Vet Res 51:140. https://doi.org/10.1186/s13567-020-00861-2 - DOI - PubMed - PMC
-
- De Alwis MCL (1992) Pasteurellosis in Production Animals: A Review. In: Patten BE, Spencer TL, Jhonson RB, Hoffmann D, Lehane L (eds) Pasteurellosis in Production Animals, ACIAR Proceddings No. 43. ACIAR, Bali, Indonesia, pp 11–18
-
- Piorunek M, Brajer-Luftmann B, Walkowiak J (2023) Pasteurella multocida Infection in Humans. Pathogens 12:1210. https://doi.org/10.3390/pathogens12101210 - DOI - PubMed - PMC
-
- Hey P, Gow P, Torresi J, Testro A (2012) Cirrhosis, cellulitis and cats: a ‘purrfect’ combination for life-threatening spontaneous bacterial peritonitis from Pasteurella multocida. BMJ Case Rep bcr 2012007397. https://doi.org/10.1136/bcr-2012-007397
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
